Coordinatore | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Organization address
address: BELFIELD contact info |
Nazionalità Coordinatore | Ireland [IE] |
Sito del progetto | http://www.neuronano.eu |
Totale costo | 4˙823˙050 € |
EC contributo | 2˙498˙000 € |
Programma | FP7-NMP
Specific Programme "Cooperation": Nanosciences, Nanotechnologies, Materials and new Production Technologies |
Code Call | FP7-NMP-2007-SMALL-1 |
Funding Scheme | CP-FP |
Anno di inizio | 2009 |
Periodo (anno-mese-giorno) | 2009-02-01 - 2012-01-31 |
# | ||||
---|---|---|---|---|
1 |
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Organization address
address: BELFIELD contact info |
IE (DUBLIN) | coordinator | 884˙061.75 |
2 |
UNIVERSITY OF ULSTER
Organization address
address: CROMORE ROAD contact info |
UK (COLERAINE) | participant | 420˙617.00 |
3 |
JRC -JOINT RESEARCH CENTRE- EUROPEAN COMMISSION
Organization address
address: Rue de la Loi 200 contact info |
BE (BRUSSELS) | participant | 352˙200.00 |
4 |
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Organization address
address: Ingolstaedter Landstrasse 1 contact info |
DE (MUENCHEN) | participant | 337˙500.00 |
5 |
THE UNIVERSITY OF EDINBURGH
Organization address
address: OLD COLLEGE, SOUTH BRIDGE contact info |
UK (EDINBURGH) | participant | 251˙621.25 |
6 |
UNIVERSITY COLLEGE CORK, NATIONAL UNIVERSITY OF IRELAND, CORK
Organization address
address: Western Road contact info |
IE (CORK) | participant | 167˙000.00 |
7 |
UNIVERSIDADE FEDERAL DO CEARA
Organization address
address: AVENIDA DA UNIVERSIDADE 2853 contact info |
BR (FORTALEZA) | participant | 85˙000.00 |
8 |
NATIONAL INSTITUTE FOR MATERIALS SCIENCE
Organization address
address: SENGEN 1-2-1 contact info |
JP (TSUKUBA) | participant | 0.00 |
9 |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Organization address
address: "FRANKLIN STREET 1111, 12 FLOOR" contact info |
US (OAKLAND CA) | participant | 0.00 |
10 |
UNIVERSITY OF ROCHESTER
Organization address
address: "ELMWOOD AVENUE, BOX EHSC 601" contact info |
US (ROCHESTER NY) | participant | 0.00 |
11 |
WILLIAM MARSH RICE UNIVERSITY
Organization address
address: MAIN STREET 6100 contact info |
US (HOUSTON TEXAS) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'As the use of nanoparticles becomes more prevalent, it is clear that human exposure will inevitably increase. Considering the rapidly ageing European population and the resulting increase in the incidence of neurodegenerative diseases, there is an urgent need to address the risk presented by nanoparticles towards neurodegenerative diseases. It is believed that nanoparticles can pass through the blood-brain barrier. Once in the brain, nanoparticles have two potential major effects. They can induce oxidative activity (production of Reactive Oxygen Species), and can induce anomalous protein aggregation behaviour (fibrillation). There are multiple disease targets for the nanoparticles, including all of the known fibrillation diseases (e.g. Alzheimer’s and Parkinson’s diseases). The factors that determine which nanoparticles enter the brain are not known. Nanoparticle size, shape, rigidity and composition are considered important, and under physiological conditions, the nature of the adsorbed biomolecule corona (proteins, lipids etc.) determines the biological responses. The NeuroNano project will investigate the detailed mechanisms of nanoparticle passage through the blood-brain barrier using primary cell co-cultures and animal studies. Using nanoparticles that are shown to reach the brain, we will determine the mechanisms of ROS production and protein fibrillation, using state-of-the-art approaches such as redox proteomics and isolation/characterisation of the critical pre-fibrillar species. Animal models for Alzheimer’s diseases will confirm the effects of the nanoparticles in vivo. At all stages the exact nature of the nanoparticle biomolecule corona will be determined. The result will be a risk-assessment framework for assessing the safety of nanoparticles towards neurodegenerative diseases, based on the connection of their biological effects to their biomolecule corona, which determines the biological response in vivo and reports on the nanoparticles’ history.'
Engineered nanoparticles (NPs) are miniature entities of materials also manufactured in bulk but with very different properties. As their prevalence increases, it is critical to evaluate the potential impact on public health.
Mitigation of risk and control of exposure in nanotechnology based inks and pigments - NANOMICEX -
Read MoreModern polymer-based catalysts and microflow conditions as key elements of innovations in fine chemical syntheses
Read MoreStrengthening the industries’ competitive position by the development of a logistical and technological system for “spare parts” that is based on on-demand production
Read More